UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 1, 2021
Accession Number:
0001213900-21-050776
Submission Type:
POS AM
CIK:
0001783036
Company Name:
NLS Pharmaceutics Ltd.
File Number:
333-236797